Do Not Hold Metoprolol for a Heart Rate of 57 BPM
A heart rate of 57 beats per minute is not an absolute contraindication to metoprolol administration, and the decision to hold the medication should be based on the clinical context, presence of symptoms, and specific contraindications rather than this heart rate alone.
Clinical Decision Framework
When to Continue Metoprolol at HR 57
The FDA drug label for metoprolol does not specify 57 bpm as a threshold for holding the medication 1. The key considerations are:
- Asymptomatic bradycardia: If the patient has no symptoms (dizziness, syncope, fatigue, hypotension), metoprolol can generally be continued
- Chronic stable rate: Patients on chronic beta-blocker therapy often have resting heart rates in the 50s as an expected therapeutic effect
- Post-MI patients: Guidelines support beta-blocker use even with lower heart rates when clinically stable 2
When to Hold or Reduce Metoprolol
Absolute contraindications per FDA labeling 1:
- Heart rate < 45 bpm (this is the specific threshold)
- Second- or third-degree heart block
- Significant first-degree heart block (PR interval ≥ 0.24 sec)
- Systolic blood pressure < 100 mmHg
- Moderate-to-severe cardiac failure with decompensation
Relative cautions requiring dose adjustment 1:
- Symptomatic bradycardia (dizziness, presyncope, fatigue)
- Heart rate consistently 45-49 bpm with systolic BP > 100 mmHg: delay dose by 12 hours
- Development of heart failure symptoms
- Sinus node dysfunction or conduction disorders
Context-Specific Guidance
Acute Settings (AF/SVT Rate Control)
For acute atrial fibrillation or SVT, guidelines support metoprolol administration with heart rates well above 57 bpm as the target 3, 4, 5. The 2010 AHA guidelines specify metoprolol dosing of 5 mg IV over 1-2 minutes, repeated every 5 minutes up to 15 mg total, with side effects listed as "hypotension, bradycardia, precipitation of heart failure" but no specific HR cutoff 3.
Post-Myocardial Infarction
The 2013 ACCF/AHA STEMI guidelines recommend oral beta-blockers in the first 24 hours for patients without signs of heart failure, low output state, or increased risk for cardiogenic shock 2. A heart rate of 57 bpm alone does not constitute a contraindication in this setting if the patient is hemodynamically stable.
Chronic Maintenance Therapy
For chronic heart failure and hypertension management, beta-blockers are titrated to effect 6, 5. Research shows that metoprolol produces dose-dependent heart rate reduction, with mean 24-hour heart rates in therapeutic ranges often in the 60s 7. A resting HR of 57 is within expected therapeutic response.
Practical Algorithm
Check these parameters before holding metoprolol at HR 57:
- Is HR < 45 bpm? → If yes, hold dose
- Is patient symptomatic? (lightheaded, weak, syncopal) → If yes, hold or reduce dose
- Is systolic BP < 100 mmHg? → If yes, hold dose
- Is there new/worsening heart failure? → If yes, hold and reassess
- Is there high-grade AV block? → If yes, hold dose
If all answers are NO: Continue metoprolol as prescribed
Common Pitfalls
- Over-reliance on arbitrary heart rate thresholds: The cutoff is 45 bpm, not 60 bpm 1
- Ignoring clinical context: A well-tolerated HR of 57 in a chronic beta-blocker user is different from acute symptomatic bradycardia
- Confusing target heart rates with holding parameters: Target HRs for rate control (50-60 bpm for ACS 8) are goals, not contraindications
- Not assessing blood pressure: Hypotension is often more concerning than isolated bradycardia 1
The POISE trial demonstrated increased mortality with perioperative metoprolol when it caused hypotension and bradycardia 9, emphasizing that hemodynamic consequences matter more than the heart rate number itself.